Comparison of CD20 expression in B‐cell lymphoma between newly diagnosed, untreated cases and those after rituximab treatment

Few studies have statistically investigated reduced CD20 expression in B‐cell lymphoma after rituximab therapy and genomic mutation of CD20 associated with reduction. We examined CD20‐positive rate in follicular lymphoma (FL) and diffuse large B‐cell lymphoma (DLBCL) by flow cytometry (FCM) and immu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Sci
Hauptverfasser: Miyoshi, Hiroaki, Arakawa, Fumiko, Sato, Kensaku, Kimura, Yoshizo, Kiyasu, Junichi, Takeuchi, Masanori, Yoshida, Maki, Ichikawa, Ayako, Ishibashi, Yukinao, Nakamura, Yukihiko, Nakashima, Shinji, Niino, Daisuke, Sugita, Yasuo, Ohshima, Koichi
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2012
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7659217/
https://ncbi.nlm.nih.gov/pubmed/22500644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2012.02307.x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge